Antibody and T Cell Responses against Wild-Type and Omicron SARS-CoV-2 after Third-Dose BNT162b2 in Adolescents

By
lbeveridge
-
0
204
Researchers evaluated the humoral and cellular responses against wild-type and Omicron SARS-CoV-2 before and after a third dose of BNT162b2 in healthy adolescents.
[Signal Transduction and Targeted Therapy]
Full Article